CNBX
CNBX Pharmaceuticals Inc.Company with tickers: CNBX
CIK
1343009
CUSIP
13764M209
Shares Outstanding
1,225,768,095
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | $0 | USD | 2026-02-28 | 10-Q | 2026-04-14 |
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | $0 | USD | 2026-02-28 | 10-Q | 2026-04-14 |
| Gross Profit | $0 | USD | 2026-02-28 | 10-Q | 2026-04-14 |
| Operating Expenses | $136,965 | USD | 2026-02-28 | 10-Q | 2026-04-14 |
| Research & Development | $0 | USD | 2026-02-28 | 10-Q | 2026-04-14 |
| Operating Income | $-136,965 | USD | 2026-02-28 | 10-Q | 2026-04-14 |
| Net Income | $-69,788 | USD | 2025-02-28 | 10-Q | 2026-04-14 |
| EPS (Basic) | $0.00 | USD/shares | 2026-02-28 | 10-Q | 2026-04-14 |
| EPS (Diluted) | $0.00 | USD/shares | 2026-02-28 | 10-Q | 2026-04-14 |